𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis

✍ Scribed by Libor Vítek; Miroslava Zelenková; Radan Brůha

Book ID
119229741
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
66 KB
Volume
42
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid inhibits eosinophil
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis
✍ Kiyoshi Yamazaki; Kazuyuki Suzuki; Atsushi Nakamura; Shunichi Sato; Keith D. Lin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

Eosinophilia is a distinctive feature of primary biliary cirrhosis (PBC), especially in its early stages. Intriguingly, treatment with ursodeoxycholic acid (UDCA) ameliorates eosinophilia as well as liver tests in patients with PBC. It remains unknown, however, whether eosinophils in PBC patients ar

Cholesterol-lowering effect of ursodeoxy
Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis
✍ Renée E. Poupon; Khadija Ouguerram; Yves Chrétien; Claudine Verneau; Eveline Esc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids